Owkin, a pioneering TechBio company, has announced a strategic collaboration with Amazon Web Services (AWS) to innovate in the field of drug discovery, enhance clinical trials, and advance AI diagnostics. This partnership is set to leverage AWS’s global infrastructure and cloud platform capabilities to boost data operations and accelerate research in precision medicine, aiming to […]
Eli Lilly and Company (Lilly), a global leader in pharmaceuticals, has made headlines with its announcement to acquire Loxo Oncology, a pioneering biopharmaceutical company based in Stamford, Connecticut. The all-cash deal, valued at $8 billion, is poised to significantly enhance Lilly’s oncology portfolio by integrating Loxo Oncology’s cutting-edge precision medicines. A strategic move in oncology […]
